• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MUC1 在肾细胞癌中的作用。

The Role of MUC1 in Renal Cell Carcinoma.

机构信息

Urology, Andrology and Kidney Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", 70124 Bari, Italy.

Division of Urology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 71013 Milan, Italy.

出版信息

Biomolecules. 2024 Mar 7;14(3):315. doi: 10.3390/biom14030315.

DOI:10.3390/biom14030315
PMID:38540735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10967890/
Abstract

Mucins are a family of high-molecular-weight glycoproteins. MUC1 is widely studied for its role in distinct types of cancers. In many human epithelial malignancies, MUC1 is frequently overexpressed, and its intracellular activities are crucial for cell biology. MUC1 overexpression can enhance cancer cell proliferation by modulating cell metabolism. When epithelial cells lose their tight connections, due to the loss of polarity, the mucins become dispersed on both sides of the epithelial membrane, leading to an abnormal mucin interactome with the membrane. Tumor-related MUC1 exhibits certain features, such as loss of apical localization and aberrant glycosylation that might cause the formation of tumor-related antigen epitopes. Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and it is the most common kidney cancer. The exact role of MUC1 in this tumor is unknown. Evidence suggests that it may play a role in several oncogenic pathways, including proliferation, metabolic reprogramming, chemoresistance, and angiogenesis. The purpose of this review is to explore the role of MUC1 and the meaning of its overexpression in epithelial tumors and in particular in RCC.

摘要

黏蛋白是一类高分子量糖蛋白。MUC1 因其在不同类型癌症中的作用而被广泛研究。在许多人类上皮恶性肿瘤中,MUC1 常过表达,其细胞内活性对细胞生物学至关重要。MUC1 的过表达可通过调节细胞代谢来增强癌细胞的增殖。当上皮细胞因极性丧失而失去紧密连接时,黏蛋白会在上皮膜的两侧分散,导致黏蛋白与膜的异常互作。肿瘤相关的 MUC1 表现出某些特征,如顶端定位丧失和异常糖基化,这可能导致肿瘤相关抗原表位的形成。肾细胞癌(RCC)约占成人恶性肿瘤的 3%,是最常见的肾癌。MUC1 在这种肿瘤中的确切作用尚不清楚。有证据表明,它可能在几种致癌途径中发挥作用,包括增殖、代谢重编程、化疗耐药和血管生成。本综述的目的是探讨 MUC1 的作用及其在上皮肿瘤中,特别是在 RCC 中的过表达的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429e/10967890/3d7c9e04a523/biomolecules-14-00315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429e/10967890/3d7c9e04a523/biomolecules-14-00315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429e/10967890/3d7c9e04a523/biomolecules-14-00315-g001.jpg

相似文献

1
The Role of MUC1 in Renal Cell Carcinoma.MUC1 在肾细胞癌中的作用。
Biomolecules. 2024 Mar 7;14(3):315. doi: 10.3390/biom14030315.
2
Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.MUC1粘蛋白的表达与肾细胞癌患者术后生存率呈负相关。
Br J Cancer. 1999 Apr;80(1-2):301-8. doi: 10.1038/sj.bjc.6690355.
3
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome.MUC1 组织表达及其可溶性形式 CA15-3 可识别出一种具有独特代谢特征和不良临床结局的透明细胞肾细胞癌。
Int J Mol Sci. 2022 Nov 12;23(22):13968. doi: 10.3390/ijms232213968.
4
Expression of epithelial mucins Muc1, Muc2, and Muc3 in ductal carcinoma in situ of the breast.上皮黏蛋白Muc1、Muc2和Muc3在乳腺导管原位癌中的表达。
Breast J. 2001 Jan-Feb;7(1):40-5. doi: 10.1046/j.1524-4741.2001.007001040.x.
5
Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.涎腺黏液表皮样癌中膜结合黏蛋白(MUC1和MUC4)及分泌性黏蛋白(MUC2、MUC5AC、MUC5B、MUC6和MUC7)的表达
Am J Surg Pathol. 2005 Jun;29(6):806-13. doi: 10.1097/01.pas.0000155856.84553.c9.
6
Expression of human mucin genes in normal kidney and renal cell carcinoma.人黏蛋白基因在正常肾脏和肾细胞癌中的表达。
Histopathology. 2002 May;40(5):450-7. doi: 10.1046/j.1365-2559.2002.01408.x.
7
Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16.人类癌相关跨膜黏蛋白MUC1、MUC4和MUC16的独特进化
Gene. 2006 May 24;373:28-34. doi: 10.1016/j.gene.2005.12.021. Epub 2006 Feb 24.
8
[MUC1, a therapeutic target in oncology].[MUC1,肿瘤学中的一个治疗靶点]
Bull Cancer. 2007 Mar;94(3):253-7.
9
Immunohistochemical expression profiles of MUC1 and MUC2 mucins in urothelial tumors of bladder.MUC1和MUC2黏蛋白在膀胱尿路上皮肿瘤中的免疫组化表达谱
Indian J Pathol Microbiol. 2018 Jul-Sep;61(3):350-355. doi: 10.4103/IJPM.IJPM_12_18.
10
Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.黏蛋白(MUC1、MUC2、MUC3、MUC4、MUC5AC和MUC6)在人乳腺癌中的表达及其预后意义。
Mod Pathol. 2005 Oct;18(10):1295-304. doi: 10.1038/modpathol.3800445.

引用本文的文献

1
Evaluation of the Expression of IDO and PTEN in Human Kidney Cancer.人肾癌中吲哚胺 2,3-双加氧酶(IDO)和第 10 号染色体缺失的磷酸酶及张力蛋白同源物(PTEN)表达的评估
Curr Issues Mol Biol. 2025 May 13;47(5):359. doi: 10.3390/cimb47050359.
2
Advances in immunotherapy and targeted therapy for advanced clear-cell renal cell carcinoma: current strategies and future directions.晚期透明细胞肾细胞癌免疫治疗和靶向治疗的进展:当前策略与未来方向
Front Immunol. 2025 Jul 3;16:1582887. doi: 10.3389/fimmu.2025.1582887. eCollection 2025.
3
The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets.

本文引用的文献

1
MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma.MUC1-EGFR 与 IL-6 通过激活 NF-κB 和 MAPK 通路相互作用,调节肺腺癌的干性和紫杉醇耐药性。
Ann Med. 2024 Dec;56(1):2313671. doi: 10.1080/07853890.2024.2313671. Epub 2024 Feb 7.
2
Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host.嵌合抗原受体 T 细胞靶向黏蛋白-1 对免疫功能正常的宿主实体瘤具有疗效和安全性。
J Immunother. 2024 Apr 1;47(3):77-88. doi: 10.1097/CJI.0000000000000505. Epub 2024 Jan 25.
3
黏蛋白家族在肺癌中的多方面作用:从预后生物标志物到有前景的靶点。
Front Immunol. 2025 Jun 27;16:1608140. doi: 10.3389/fimmu.2025.1608140. eCollection 2025.
4
The role of in regulating proliferation and invasion in U251 glioblastoma cells.在U251胶质母细胞瘤细胞中调节增殖和侵袭的作用。 (原文“of”后面缺少具体内容)
Contemp Oncol (Pozn). 2025;29(2):195-205. doi: 10.5114/wo.2025.150649. Epub 2025 May 12.
5
Identification of CENPW as a prognostic biomarker and potential therapeutic target for clear cell renal cell carcinoma.鉴定CENPW作为透明细胞肾细胞癌的预后生物标志物和潜在治疗靶点。
Discov Oncol. 2025 Jun 18;16(1):1138. doi: 10.1007/s12672-025-02859-8.
6
Migrasome-related lncRNAs predict prognosis and immune response of clear cell renal cell carcinoma.与迁移小体相关的长链非编码RNA预测透明细胞肾细胞癌的预后和免疫反应。
Transl Androl Urol. 2025 May 30;14(5):1214-1229. doi: 10.21037/tau-2024-728. Epub 2025 May 27.
7
Analysis of immune status and prognostic model incorporating lactate metabolism and immune-related genes in clear cell renal cell carcinoma.透明细胞肾细胞癌中免疫状态分析及结合乳酸代谢和免疫相关基因的预后模型
Discov Oncol. 2025 Jun 7;16(1):1024. doi: 10.1007/s12672-025-02746-2.
8
Proteomics and succinylation modification characterization in clear cell renal cell carcinoma.透明细胞肾细胞癌中的蛋白质组学与琥珀酰化修饰特征分析
Discov Oncol. 2025 May 20;16(1):835. doi: 10.1007/s12672-025-02737-3.
9
LPCAT3 regulates the immune infiltration and prognosis of ccRCC patients by mediating ferroptosis and endoplasmic reticulum stress.LPCAT3通过介导铁死亡和内质网应激来调节ccRCC患者的免疫浸润和预后。
Discov Oncol. 2025 Apr 19;16(1):574. doi: 10.1007/s12672-025-02283-y.
10
The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma.肾细胞癌中代谢重编程的发病机制及治疗意义
Cell Death Discov. 2025 Apr 19;11(1):186. doi: 10.1038/s41420-025-02479-9.
MUC1 Drives the Progression and Chemoresistance of Clear Cell Renal Carcinomas.
MUC1驱动透明细胞肾细胞癌的进展和化疗耐药性。
Cancers (Basel). 2024 Jan 17;16(2):391. doi: 10.3390/cancers16020391.
4
MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells.MUC1-C是沙林霉素诱导癌症干细胞铁死亡的靶点。
Cell Death Discov. 2024 Jan 5;10(1):9. doi: 10.1038/s41420-023-01772-9.
5
Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy.黏蛋白1作为癌症免疫治疗和靶向治疗的潜在分子。
J Cancer. 2024 Jan 1;15(1):54-67. doi: 10.7150/jca.88261. eCollection 2024.
6
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma.补体系统与肾脏:在肾脏疾病、肾移植和肾细胞癌中的作用。
Int J Mol Sci. 2023 Nov 20;24(22):16515. doi: 10.3390/ijms242216515.
7
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers.肾细胞癌中的癌症干细胞:起源和生物标志物。
Int J Mol Sci. 2023 Aug 24;24(17):13179. doi: 10.3390/ijms241713179.
8
Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody.新型MUC1/CD3双特异性抗体对MUC1过表达肿瘤的抑制作用
Antibodies (Basel). 2023 Jul 13;12(3):47. doi: 10.3390/antib12030047.
9
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma.肾细胞癌肿瘤微环境中的细胞与分子参与者
J Clin Med. 2023 Jun 7;12(12):3888. doi: 10.3390/jcm12123888.
10
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice.肾细胞癌中的免疫检查点抑制剂:其在临床实践中应用的分子基础和原理
Biomedicines. 2023 Apr 2;11(4):1071. doi: 10.3390/biomedicines11041071.